Desarrollo y validación del test MaiRa
Hemos llevado a cabo un estudio clínico prospectivo multicéntrico que ha permitido demostrar la sensibilidad y especificidad del ARN libre circulante en el cribado precoz de la preeclampsia.
ClinicalTrials.gov: NCT04990141 (finalizado)
Study characteristics
14 participating hospitals
~9,600 pregnant women included
26,000 samples collected
Longitudinal design by trimester
Objectives → Development of a predictive model based on cfRNA → Identification of a molecular signature associated with preeclampsia
Result: development of MaiRa
A partir de este ensayo estudio se ha logrado:
Identifying a patented cfRNA molecular signature
Developing a predictive algorithm based on artificial intelligence
Validar el modelo predictivo
This study has made possible the development of the first blood test for the early prediction of the risk of preeclampsia.